ESH-iCMLf 13th International Conference CHRONIC MYELOID LEUKEMIA - Biology and Therapy

Search’n Build™

Use this index to quickly access speakers by name. A  B  C  D  E  F  G  H  I   J  K  L  M  N  O  P  Q   R  S  T  U   V  W  X   Y  Z  

Scroll down to see presentations grouped by speakers.
A
Jane Apperley  

Keynote lecture: What questions remain and how can we answer them?
2011-09-22 - English
to be announced!



C

D
Mike Deininger  

Finding the soft spot: targeting CML stem cells
2011-09-22 - English
available!

Panel Discussion  

General Discussion
2011-09-22 - English
available!

Panel Discussion  

General discussion
2011-09-23 - English
to be announced!

Panel Discussion  

Debate
2011-09-22 - English
to be announced!

Panel Discussion  

Debate
2011-09-22 - English
to be announced!

Panel Discussion  

Debate
2011-09-22 - English

Panel Discussion  

Debate
2011-09-25 - English
to be announced!

Panel Discussion  

Debate
2011-09-25 - English
available!

Panel Discussion  

Debate
2011-09-25 - English
to be announced!

Justus Duyster  

RAF1 is a crucial mediator of BCR-ABL driven leukemogenesis
2011-09-22 - English
to be announced!



F
Thoas Fioretos  

IL1-RAP update
2011-09-22 - English
to be announced!


G





M
François-Xavier Mahon  

Stopping TKI can now be recommended in selected patients: yes
2011-09-25 - English

David Marin  

Assessment of BCR-ABL1 transcripts at 3 months predicts patient outcome
2011-09-22 - English
to be announced!

Giovanni Martinelli  

All CML patients should start treatment with 2G-TKI: yes
2011-09-25 - English
to be announced!

Giovanni Martinelli  

There is a definite need to target stem cells: no
2011-09-22 - English

Markus Müschen  

Targeting inhibitory phosphatase signaling in CML
2011-09-22 - English
to be announced!



O
Stephen O'Brien  

How do we define the \'best\' front-line therapy for CML and can we afford it?
2011-09-22 - English
available!




S
Anil Sadarangani  

Elucidation of novel epigenetic mechanisms driving human LSC generation
2011-09-22 - English
to be announced!

Giuseppe Saglio  

Stopping TKI can now be recommended in selected partients: no
2011-09-25 - English

Martin Sattler  

Genomic instability can be manipulated to induce LSC to self-destruct: no
2011-09-22 - English
to be announced!

David Scheinberg  

Keynote Lecture: Vaccine and antibody therapy for CML
2011-09-22 - English
to be announced!

Charles Schiffer  

All CML patients should start treatment with 2G-TKI: no
2011-09-25 - English
available!

Mary Scott  

Targeting DNA checkpoint/repair proteins as a strategy for the treatment of CML
2011-09-22 - English
to be announced!

Tomasz Skorski  

Genomic instability can be manipulated to induce LSC to self-destruct: yes
2011-09-22 - English
to be announced!

Giulio Superti-Furga  

Targeting the BCR-ABL/SH2 interface
2011-09-22 - English
to be announced!







Use this index to quickly access speakers by name. A  B  C  D  E  F  G  H  I   J  K  L  M  N  O  P  Q   R  S  T  U   V  W  X   Y  Z